MedTrace Logo

Clinical Practices for Treating Severe Malaria Caused by P. Falciparum

NCT07027722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2025-06-18

No results posted yet for this study

Summary

This study looks at how doctors in three hospitals in France treat patients with a serious form of malaria caused by Plasmodium falciparum. It focuses on cases where the level of malaria parasites in the blood is 4% or higher. The study will compare how often a type of medicine called ACT (artemisinin-based combination therapy) is used on its own instead of the usual first-choice treatment (intravenous artesunate), and whether ACT works just as well. It will also check how well patients recover, whether they have complications, and how long they stay in the hospital.

Conditions

  • Malaria, Falciparum
  • Plasmodium Falciparum
  • Antimalarials
  • Artemisinins
  • Treatment Outcome
  • Drug Therapy, Combination
  • Retrospective Studies
  • Hospitalization

Sponsors & Collaborators

  • Centre Hospitalier de Saint-Denis

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2024-05-31
Completion
2024-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07027722 on ClinicalTrials.gov